메뉴 건너뛰기




Volumn 168, Issue 5, 2014, Pages 632-644

Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

EID: 84908323531     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.028     Document Type: Review
Times cited : (179)

References (94)
  • 1
    • 0037077308 scopus 로고    scopus 로고
    • The immune modulator FTY720 targets sphingosine 1-phosphate receptors
    • V. Brinkmann, M.D. Davis, and C.E. Heise The immune modulator FTY720 targets sphingosine 1-phosphate receptors J Biol Chem 277 2002 21453 21457
    • (2002) J Biol Chem , vol.277 , pp. 21453-21457
    • Brinkmann, V.1    Davis, M.D.2    Heise, C.E.3
  • 2
    • 0037066466 scopus 로고    scopus 로고
    • Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
    • S. Mandala, R. Hajdu, and J. Bergstrom Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
    • (2002) Science , vol.296 , pp. 346-349
    • Mandala, S.1    Hajdu, R.2    Bergstrom, J.3
  • 5
    • 78049480679 scopus 로고    scopus 로고
    • Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis
    • V. Brinkmann, A. Billich, and T. Baumruker Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 2010 883 897
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 883-897
    • Brinkmann, V.1    Billich, A.2    Baumruker, T.3
  • 6
    • 76149093586 scopus 로고    scopus 로고
    • A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
    • L. Kappos, E.W. Radue, and P. O'Connor A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 2010 387 401
    • (2010) N Engl J Med , vol.362 , pp. 387-401
    • Kappos, L.1    Radue, E.W.2    O'Connor, P.3
  • 7
    • 76149140914 scopus 로고    scopus 로고
    • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
    • J.A. Cohen, F. Barkhof, and G. Comi Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 2010 402 415
    • (2010) N Engl J Med , vol.362 , pp. 402-415
    • Cohen, J.A.1    Barkhof, F.2    Comi, G.3
  • 8
    • 84901197534 scopus 로고    scopus 로고
    • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): A double-blind, randomised, placebo-controlled, phase 3 trial
    • P.A. Calabresi, E.W. Radue, and D. Goodin Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial Lancet Neurol 13 2014 545 556
    • (2014) Lancet Neurol , vol.13 , pp. 545-556
    • Calabresi, P.A.1    Radue, E.W.2    Goodin, D.3
  • 9
    • 85028102802 scopus 로고    scopus 로고
    • Early effect of fingolimod on clinical and MRI related outcomes in relapsing multiple sclerosis
    • P. Chin, P. Calabresi, and Y. Zhang Early effect of fingolimod on clinical and MRI related outcomes in relapsing multiple sclerosis Mult Scler 18 4 Suppl. 2012 459
    • (2012) Mult Scler , vol.18 , Issue.4 , pp. 459
    • Chin, P.1    Calabresi, P.2    Zhang, Y.3
  • 10
    • 85028100430 scopus 로고    scopus 로고
    • Fingolimod-effect on brain atrophy and clinical/MRI correlations in three phase 3 studies - TRANSFORMS, FREEDOMS and FREEDOMS II
    • [(Meeting Abstracts 1): S51.006]
    • J.A. Cohen, E.W. Radue, and F. Barkhof Fingolimod-effect on brain atrophy and clinical/MRI correlations in three phase 3 studies - TRANSFORMS, FREEDOMS and FREEDOMS II Neurology 80 2013 [(Meeting Abstracts 1): S51.006]
    • (2013) Neurology , vol.80
    • Cohen, J.A.1    Radue, E.W.2    Barkhof, F.3
  • 11
    • 70849086174 scopus 로고    scopus 로고
    • FTY720 (fingolimod) in multiple sclerosis: Therapeutic effects in the immune and the central nervous system
    • V. Brinkmann FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system Br J Pharmacol 158 2009 1173 1182
    • (2009) Br J Pharmacol , vol.158 , pp. 1173-1182
    • Brinkmann, V.1
  • 12
    • 1642580757 scopus 로고    scopus 로고
    • Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
    • M. Matloubian, C.G. Lo, and G. Cinamon Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
    • (2004) Nature , vol.427 , pp. 355-360
    • Matloubian, M.1    Lo, C.G.2    Cinamon, G.3
  • 14
    • 3042750654 scopus 로고    scopus 로고
    • Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging
    • M. Rausch, P. Hiestand, and C.A. Foster Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging J Magn Reson Imaging 20 2004 16 24
    • (2004) J Magn Reson Imaging , vol.20 , pp. 16-24
    • Rausch, M.1    Hiestand, P.2    Foster, C.A.3
  • 15
    • 77951073508 scopus 로고    scopus 로고
    • Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis
    • J. Chun, and H.P. Hartung Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis Clin Neuropharmacol 33 2010 91 101
    • (2010) Clin Neuropharmacol , vol.33 , pp. 91-101
    • Chun, J.1    Hartung, H.P.2
  • 16
    • 35348970884 scopus 로고    scopus 로고
    • Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
    • C.A. Foster, L.M. Howard, and A. Schweitzer Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J Pharmacol Exp Ther 323 2007 469 475
    • (2007) J Pharmacol Exp Ther , vol.323 , pp. 469-475
    • Foster, C.A.1    Howard, L.M.2    Schweitzer, A.3
  • 17
    • 84959913458 scopus 로고    scopus 로고
    • Brain distribution of BZM055, an analog of fingolimod (FTY720), in humans
    • G. Tamagnan, A. Tavares, and O. Barret Brain distribution of BZM055, an analog of fingolimod (FTY720), in humans Mult Scler 18 4 Suppl. 2012 839
    • (2012) Mult Scler , vol.18 , Issue.4 , pp. 839
    • Tamagnan, G.1    Tavares, A.2    Barret, O.3
  • 18
    • 84876119766 scopus 로고    scopus 로고
    • Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
    • A. Groves, Y. Kihara, and J. Chun Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy J Neurol Sci 328 2013 9 18
    • (2013) J Neurol Sci , vol.328 , pp. 9-18
    • Groves, A.1    Kihara, Y.2    Chun, J.3
  • 19
    • 80054052730 scopus 로고    scopus 로고
    • Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors
    • V.A. Blaho, and T. Hla Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors Chem Rev 111 2011 6299 6320
    • (2011) Chem Rev , vol.111 , pp. 6299-6320
    • Blaho, V.A.1    Hla, T.2
  • 20
    • 34250832664 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
    • V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol Ther 115 2007 84 105
    • (2007) Pharmacol Ther , vol.115 , pp. 84-105
    • Brinkmann, V.1
  • 21
    • 67449138784 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate receptor signalling in the heart
    • C.K. Means, and J.H. Brown Sphingosine-1-phosphate receptor signalling in the heart Cardiovasc Res 82 2009 193 200
    • (2009) Cardiovasc Res , vol.82 , pp. 193-200
    • Means, C.K.1    Brown, J.H.2
  • 22
    • 0037162062 scopus 로고    scopus 로고
    • Lysophospholipids and the cardiovascular system
    • J.S. Karliner Lysophospholipids and the cardiovascular system Biochim Biophys Acta 1582 2002 216 221
    • (2002) Biochim Biophys Acta , vol.1582 , pp. 216-221
    • Karliner, J.S.1
  • 23
    • 11144353922 scopus 로고    scopus 로고
    • 3, respectively, regulate lymphocyte recirculation and heart rate
    • 3, respectively, regulate lymphocyte recirculation and heart rate J Biol Chem 279 2004 13839 13848
    • (2004) J Biol Chem , vol.279 , pp. 13839-13848
    • Sanna, M.G.1    Liao, J.2    Jo, E.3
  • 24
    • 10744230053 scopus 로고    scopus 로고
    • Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients
    • K. Budde, R.L. Scmouder, and B. Nashan Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients Am J Transplant 3 2003 846 854
    • (2003) Am J Transplant , vol.3 , pp. 846-854
    • Budde, K.1    Scmouder, R.L.2    Nashan, B.3
  • 25
    • 0038218405 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate: An enigmatic signalling lipid
    • S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
    • (2003) Nat Rev Mol Cell Biol , vol.4 , pp. 397-407
    • Spiegel, S.1    Milstien, S.2
  • 26
    • 76149126108 scopus 로고    scopus 로고
    • Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning
    • T.H. Pham, P. Baluk, and Y. Xu Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning J Exp Med 207 2010 17 27
    • (2010) J Exp Med , vol.207 , pp. 17-27
    • Pham, T.H.1    Baluk, P.2    Xu, Y.3
  • 28
    • 1042278008 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells
    • J. Harada, M. Foley, and M.A. Moskowitz Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells J Neurochem 88 2004 1026 1039
    • (2004) J Neurochem , vol.88 , pp. 1026-1039
    • Harada, J.1    Foley, M.2    Moskowitz, M.A.3
  • 29
    • 79958278811 scopus 로고    scopus 로고
    • The sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development
    • R.R. Poulsen, C.M. McClaskey, and S.A. Rivkees The sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development BMC Dev Biol 11 2011 37
    • (2011) BMC Dev Biol , vol.11 , pp. 37
    • Poulsen, R.R.1    McClaskey, C.M.2    Rivkees, S.A.3
  • 30
    • 84873836098 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning
    • K. Mendelson, T. Zygmunt, and J. Torres-Vazquez Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning J Biol Chem 288 2013 2143 2156
    • (2013) J Biol Chem , vol.288 , pp. 2143-2156
    • Mendelson, K.1    Zygmunt, T.2    Torres-Vazquez, J.3
  • 31
    • 35048835160 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase
    • M. Xu, C.L. Waters, and C. Hu Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase Am J Physiol Cell Physiol 293 2007 C1309 C1318
    • (2007) Am J Physiol Cell Physiol , vol.293 , pp. C1309-C1318
    • Xu, M.1    Waters, C.L.2    Hu, C.3
  • 33
    • 58149483374 scopus 로고    scopus 로고
    • Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature
    • J.F. Lee, S. Gordon, and R. Estrada Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature Am J Physiol Heart Circ Physiol 296 2009 H33 H42
    • (2009) Am J Physiol Heart Circ Physiol , vol.296 , pp. H33-H42
    • Lee, J.F.1    Gordon, S.2    Estrada, R.3
  • 35
    • 34547915639 scopus 로고    scopus 로고
    • Attenuation of vascular permeability by methylnaltrexone: Role of mOP-R and S1P3 transactivation
    • P.A. Singleton, L. Moreno-Vinasco, and S. Sammani Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation Am J Respir Cell Mol Biol 37 2007 222 231
    • (2007) Am J Respir Cell Mol Biol , vol.37 , pp. 222-231
    • Singleton, P.A.1    Moreno-Vinasco, L.2    Sammani, S.3
  • 36
    • 0036905055 scopus 로고    scopus 로고
    • Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells
    • M. Graeler, and E.J. Goetzl Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells FASEB J 16 2002 1874 1878
    • (2002) FASEB J , vol.16 , pp. 1874-1878
    • Graeler, M.1    Goetzl, E.J.2
  • 37
    • 80355129639 scopus 로고    scopus 로고
    • 4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model
    • 4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model FASEB J 25 2011 4024 4036
    • (2011) FASEB J , vol.25 , pp. 4024-4036
    • Schulze, T.1    Golfier, S.2    Tabeling, C.3
  • 38
    • 85016365810 scopus 로고    scopus 로고
    • 4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs
    • 4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs Pulm Circ 1 2011 399 404
    • (2011) Pulm Circ , vol.1 , pp. 399-404
    • Ota, H.1    Beutz, M.A.2    Ito, M.3
  • 39
    • 13844271705 scopus 로고    scopus 로고
    • Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival
    • C. Jaillard, S. Harrison, and B. Stankoff Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival J Neurosci 25 2005 1459 1469
    • (2005) J Neurosci , vol.25 , pp. 1459-1469
    • Jaillard, C.1    Harrison, S.2    Stankoff, B.3
  • 40
    • 80855156707 scopus 로고    scopus 로고
    • Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
    • K. Mayol, V. Biajoux, and J. Marvel Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking Blood 118 2011 4863 4871
    • (2011) Blood , vol.118 , pp. 4863-4871
    • Mayol, K.1    Biajoux, V.2    Marvel, J.3
  • 41
    • 2142851264 scopus 로고    scopus 로고
    • Lysophospholipid receptors: Signaling and biology
    • I. Ishii, N. Fukushima, and X. Ye Lysophospholipid receptors: signaling and biology Ann Rev Biochem 73 2004 321 354
    • (2004) Ann Rev Biochem , vol.73 , pp. 321-354
    • Ishii, I.1    Fukushima, N.2    Ye, X.3
  • 42
    • 0347481389 scopus 로고    scopus 로고
    • Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
    • A. Billich, F. Bornancin, and P. Dévay Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases J Biol Chem 278 2003 47408 47415
    • (2003) J Biol Chem , vol.278 , pp. 47408-47415
    • Billich, A.1    Bornancin, F.2    Dévay, P.3
  • 43
    • 0344443651 scopus 로고    scopus 로고
    • Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability
    • T. Sanchez, T. Estrada-Hernandez, and J.H. Paik Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability J Biol Chem 278 2003 47281 47290
    • (2003) J Biol Chem , vol.278 , pp. 47281-47290
    • Sanchez, T.1    Estrada-Hernandez, T.2    Paik, J.H.3
  • 44
    • 0030656619 scopus 로고    scopus 로고
    • Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
    • M. Uehata, T. Ishizaki, and H. Satoh Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 1997 990 994
    • (1997) Nature , vol.389 , pp. 990-994
    • Uehata, M.1    Ishizaki, T.2    Satoh, H.3
  • 45
    • 20944434884 scopus 로고    scopus 로고
    • Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3
    • M. Tölle, B. Levkau, and P. Keul Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3 Circ Res 96 2005 913 920
    • (2005) Circ Res , vol.96 , pp. 913-920
    • Tölle, M.1    Levkau, B.2    Keul, P.3
  • 46
    • 14644408845 scopus 로고    scopus 로고
    • The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I
    • L. Koyrakh, M.I. Roman, and V. Brinkmann The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I Am J Transplant 5 2005 529 536
    • (2005) Am J Transplant , vol.5 , pp. 529-536
    • Koyrakh, L.1    Roman, M.I.2    Brinkmann, V.3
  • 48
    • 16644394172 scopus 로고    scopus 로고
    • Endothelial cell barrier regulation by sphingosine 1-phosphate
    • B.J. McVerry, and J.G. Garcia Endothelial cell barrier regulation by sphingosine 1-phosphate J Cell Biochem 92 2004 1075 1085
    • (2004) J Cell Biochem , vol.92 , pp. 1075-1085
    • McVerry, B.J.1    Garcia, J.G.2
  • 49
    • 37849001331 scopus 로고    scopus 로고
    • Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools
    • S. Salomone, E.M. Potts, and S. Tyndall Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools Br J Pharmacol 153 2008 140 147
    • (2008) Br J Pharmacol , vol.153 , pp. 140-147
    • Salomone, S.1    Potts, E.M.2    Tyndall, S.3
  • 50
    • 34247874512 scopus 로고    scopus 로고
    • Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor agonists induce ubiquitinylation and proteasomal degradation of the receptor
    • M.L. Oo, S. Thangada, and M.T. Wu Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor agonists induce ubiquitinylation and proteasomal degradation of the receptor J Biol Chem 282 2007 9082 9089
    • (2007) J Biol Chem , vol.282 , pp. 9082-9089
    • Oo, M.L.1    Thangada, S.2    Wu, M.T.3
  • 52
    • 84856249964 scopus 로고    scopus 로고
    • Fingolimod for multiple sclerosis
    • D. Pelletier, and D.A. Hafler Fingolimod for multiple sclerosis N Engl J Med 366 2012 339 347
    • (2012) N Engl J Med , vol.366 , pp. 339-347
    • Pelletier, D.1    Hafler, D.A.2
  • 53
    • 84875367110 scopus 로고    scopus 로고
    • Fingolimod phosphate promotes the neuroprotective effects of microglia
    • H. Noda, H. Takeuchi, and T. Mizuno Fingolimod phosphate promotes the neuroprotective effects of microglia J Neuroimmunol 256 2013 13 18
    • (2013) J Neuroimmunol , vol.256 , pp. 13-18
    • Noda, H.1    Takeuchi, H.2    Mizuno, T.3
  • 54
    • 33747419124 scopus 로고    scopus 로고
    • Pulmonary and vascular pharmacology of sphingosine 1-phosphate
    • V. Brinkmann, and T. Baumruker Pulmonary and vascular pharmacology of sphingosine 1-phosphate Curr Opin Pharmacol 6 2006 244 250
    • (2006) Curr Opin Pharmacol , vol.6 , pp. 244-250
    • Brinkmann, V.1    Baumruker, T.2
  • 55
    • 11144355672 scopus 로고    scopus 로고
    • Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
    • M. Forrest, S.Y. Sun, and R. Hajdu Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes J Pharmacol Exp Ther 309 2004 758 768
    • (2004) J Pharmacol Exp Ther , vol.309 , pp. 758-768
    • Forrest, M.1    Sun, S.Y.2    Hajdu, R.3
  • 58
    • 0035374461 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
    • M. Morales-Ruiz, M.J. Lee, and S. Zollner Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells J Biol Chem 276 2001 19672 19677
    • (2001) J Biol Chem , vol.276 , pp. 19672-19677
    • Morales-Ruiz, M.1    Lee, M.J.2    Zollner, S.3
  • 59
    • 2442699980 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate receptors: Receptor specificity versus functional redundancy
    • T.A. Taha, K.M. Argraves, and L.M. Obeid Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy Biochim Biophys Acta 1682 2004 48 55
    • (2004) Biochim Biophys Acta , vol.1682 , pp. 48-55
    • Taha, T.A.1    Argraves, K.M.2    Obeid, L.M.3
  • 60
    • 34047253376 scopus 로고    scopus 로고
    • Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors
    • M. Osinde, F. Mullershausen, and K.K. Dev Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors Neuropharmacology 52 2007 1210 1218
    • (2007) Neuropharmacology , vol.52 , pp. 1210-1218
    • Osinde, M.1    Mullershausen, F.2    Dev, K.K.3
  • 61
    • 0037178737 scopus 로고    scopus 로고
    • Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: Differential role in vasoconstriction
    • F. Coussin, R.H. Scott, and A. Wise Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction Circ Res 91 2002 151 157
    • (2002) Circ Res , vol.91 , pp. 151-157
    • Coussin, F.1    Scott, R.H.2    Wise, A.3
  • 62
    • 0038730511 scopus 로고    scopus 로고
    • 3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
    • 3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate Eur J Pharmacol 469 2003 125 134
    • (2003) Eur J Pharmacol , vol.469 , pp. 125-134
    • Salomone, S.1    Yoshimura, S.2    Reuter, U.3
  • 63
    • 4744340005 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats
    • D.G. Hemmings, Y. Xu, and S.T. Davidge Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats Br J Pharmacol 143 2004 276 284
    • (2004) Br J Pharmacol , vol.143 , pp. 276-284
    • Hemmings, D.G.1    Xu, Y.2    Davidge, S.T.3
  • 64
    • 4644259224 scopus 로고    scopus 로고
    • Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors
    • C. Waeber, N. Blondeau, and S. Salomone Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors Drug News Perspect 17 2004 365 382
    • (2004) Drug News Perspect , vol.17 , pp. 365-382
    • Waeber, C.1    Blondeau, N.2    Salomone, S.3
  • 66
    • 9644260561 scopus 로고    scopus 로고
    • The role of sphingosine-1-phosphate in smooth muscle contraction
    • K.R. Watterson, P.H. Ratz, and S. Spiegel The role of sphingosine-1-phosphate in smooth muscle contraction Cell Signal 17 2005 289 298
    • (2005) Cell Signal , vol.17 , pp. 289-298
    • Watterson, K.R.1    Ratz, P.H.2    Spiegel, S.3
  • 67
    • 33747428177 scopus 로고    scopus 로고
    • 2 receptor function in smooth muscle by receptor silencing and receptor protection
    • 2 receptor function in smooth muscle by receptor silencing and receptor protection Am J Physiol Gastrointest Liver Physiol 291 2006 G605 G610
    • (2006) Am J Physiol Gastrointest Liver Physiol , vol.291 , pp. G605-G610
    • Hu, W.1    Mahavadi, S.2    Huang, J.3
  • 68
    • 33846405257 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-mediated myosin phosphatase inactivation
    • H. Kume, N. Takeda, and T. Oguma Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-mediated myosin phosphatase inactivation J Pharmacol Exp Ther 320 2007 766 773
    • (2007) J Pharmacol Exp Ther , vol.320 , pp. 766-773
    • Kume, H.1    Takeda, N.2    Oguma, T.3
  • 69
    • 0036205659 scopus 로고    scopus 로고
    • First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients
    • K. Budde, R.L. Schmouder, and R. Brunkhorst First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients J Am Soc Nephrol 13 2002 1073 1083
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1073-1083
    • Budde, K.1    Schmouder, R.L.2    Brunkhorst, R.3
  • 70
    • 79955432850 scopus 로고    scopus 로고
    • [Accessed December 4, 2013]
    • Gilenya Summary of Product Characteristics http://www.medicines.org.uk/emc/medicine/24443/SPC 2013 [Accessed December 4, 2013]
    • (2013) Gilenya Summary of Product Characteristics
  • 71
  • 73
    • 0033572668 scopus 로고    scopus 로고
    • + current diversity in mouse ventricular myocytes
    • + current diversity in mouse ventricular myocytes J Physiol 521 1999 587 599
    • (1999) J Physiol , vol.521 , pp. 587-599
    • Guo, W.1    Xu, H.2    London, B.3
  • 74
    • 84938838488 scopus 로고    scopus 로고
    • First-dose effects of fingolimod: Pooled safety data from three phase 3 studies
    • J.P. DiMarco, P. O'Connor, and J.A. Cohen First-dose effects of fingolimod: Pooled safety data from three phase 3 studies Mult Scler Relat Disord 3 2014 629 638
    • (2014) Mult Scler Relat Disord , vol.3 , pp. 629-638
    • Dimarco, J.P.1    O'Connor, P.2    Cohen, J.A.3
  • 75
    • 0036151570 scopus 로고    scopus 로고
    • The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist
    • M. Yamada The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist J Pharmacol Exp Ther 300 2002 681 687
    • (2002) J Pharmacol Exp Ther , vol.300 , pp. 681-687
    • Yamada, M.1
  • 76
    • 84867319781 scopus 로고    scopus 로고
    • The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
    • P. Gergely, B. Nuesslein-Hildesheim, and D. Guerini The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate Br J Pharmacol 16 2012 1035 1047
    • (2012) Br J Pharmacol , vol.16 , pp. 1035-1047
    • Gergely, P.1    Nuesslein-Hildesheim, B.2    Guerini, D.3
  • 77
    • 84860167748 scopus 로고    scopus 로고
    • Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients
    • J.B. Moberly, D.M. Ford, and H. Zahir Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients J Neuroimmunol 246 2012 100 107
    • (2012) J Neuroimmunol , vol.246 , pp. 100-107
    • Moberly, J.B.1    Ford, D.M.2    Zahir, H.3
  • 78
    • 0036239322 scopus 로고    scopus 로고
    • Cell type-specific localization of human cardiac S1P receptors
    • D. Mazurais, P. Robert, and B. Gout Cell type-specific localization of human cardiac S1P receptors J Histochem Cytochem 50 2002 661 670
    • (2002) J Histochem Cytochem , vol.50 , pp. 661-670
    • Mazurais, D.1    Robert, P.2    Gout, B.3
  • 79
    • 0033615537 scopus 로고    scopus 로고
    • Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
    • M.J. Lee, S. Thangada, and K.P. Claffey Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate Cell 99 1999 301 312
    • (1999) Cell , vol.99 , pp. 301-312
    • Lee, M.J.1    Thangada, S.2    Claffey, K.P.3
  • 80
    • 33845949505 scopus 로고    scopus 로고
    • Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family
    • P.A. Singleton, S.M. Dudek, and S.F. Ma Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family J Biol Chem 281 2006 34381 34393
    • (2006) J Biol Chem , vol.281 , pp. 34381-34393
    • Singleton, P.A.1    Dudek, S.M.2    Ma, S.F.3
  • 82
    • 2542461296 scopus 로고    scopus 로고
    • Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury
    • X. Peng, P.M. Hassoun, and S. Sammani Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury Am J Respir Crit Care Med 169 2004 1245 1251
    • (2004) Am J Respir Crit Care Med , vol.169 , pp. 1245-1251
    • Peng, X.1    Hassoun, P.M.2    Sammani, S.3
  • 83
    • 85028116144 scopus 로고    scopus 로고
    • Peripheral and Central Nervous System Drugs Advisory Committee Meeting
    • [Accessed December 4, 2013]
    • Peripheral and Central Nervous System Drugs Advisory Committee Meeting Fingolimod (NDA 22-527) Background Package http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drudr/peripheralandcentralnervoussystemdrugsadvisorycommittee/ucm214670.pdf 2010 [Accessed December 4, 2013]
    • (2010) Fingolimod (NDA 22-527) Background Package
  • 84
    • 58449114090 scopus 로고    scopus 로고
    • Diabetic macular edema: Pathogenesis and treatment
    • N. Bhagat, R.A. Grigorian, and A. Tutela Diabetic macular edema: pathogenesis and treatment Surv Ophthalmol 54 2009 1 32
    • (2009) Surv Ophthalmol , vol.54 , pp. 1-32
    • Bhagat, N.1    Grigorian, R.A.2    Tutela, A.3
  • 85
    • 84879798337 scopus 로고    scopus 로고
    • Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
    • M.A. Zarbin, L.M. Jampol, and R.D. Jager Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis Ophthalmology 120 2013 1432 1439
    • (2013) Ophthalmology , vol.120 , pp. 1432-1439
    • Zarbin, M.A.1    Jampol, L.M.2    Jager, R.D.3
  • 86
    • 84895501035 scopus 로고    scopus 로고
    • Position and practical use of fingolimod in Europe
    • G. Comi Position and practical use of fingolimod in Europe Clin Exp Neuroimmunol 5 2014 19 33
    • (2014) Clin Exp Neuroimmunol , vol.5 , pp. 19-33
    • Comi, G.1
  • 88
    • 84899118363 scopus 로고    scopus 로고
    • Fingolimod treatment initiation experience: Cardiac and Holter electrocardiogram findings from three phase 3 studies
    • J. DiMarco, P. O'Connor, and J.A. Cohen Fingolimod treatment initiation experience: cardiac and Holter electrocardiogram findings from three phase 3 studies Mult Scler 18 4 Suppl. 2012 55 277
    • (2012) Mult Scler , vol.18 , Issue.4 , pp. 55-277
    • Dimarco, J.1    O'Connor, P.2    Cohen, J.A.3
  • 89
    • 84895445228 scopus 로고    scopus 로고
    • Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study
    • R. Gold, G. Comi, and J. Palace Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study J Neurol 261 2 2014 267 276
    • (2014) J Neurol , vol.261 , Issue.2 , pp. 267-276
    • Gold, R.1    Comi, G.2    Palace, J.3
  • 90
    • 84899650421 scopus 로고    scopus 로고
    • Cardiac effects of fingolimod after first dose administration and therapy change in patients with multiple sclerosis
    • [Meeting Abstracts 1:P01.170]
    • B. Hughes, M. Cascione, and K. McCague Cardiac effects of fingolimod after first dose administration and therapy change in patients with multiple sclerosis Neurology 80 2013 [Meeting Abstracts 1:P01.170]
    • (2013) Neurology , vol.80
    • Hughes, B.1    Cascione, M.2    McCague, K.3
  • 91
    • 84899660109 scopus 로고    scopus 로고
    • Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial
    • A. Laroni, D. Brogi, and V.B. Morra Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial BMC Neurol 14 2014 65
    • (2014) BMC Neurol , vol.14 , pp. 65
    • Laroni, A.1    Brogi, D.2    Morra, V.B.3
  • 92
    • 33745927144 scopus 로고    scopus 로고
    • FTY720: Placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects
    • R. Schmouder, D. Serra, and Y. Wang FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects J Clin Pharmacol 46 2006 895 904
    • (2006) J Clin Pharmacol , vol.46 , pp. 895-904
    • Schmouder, R.1    Serra, D.2    Wang, Y.3
  • 93
    • 85028113682 scopus 로고    scopus 로고
    • Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly treated with serotonin specific reuptake inhibitors
    • R. Bermel, R. Hashmonay, and X. Meng Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly treated with serotonin specific reuptake inhibitors Mult Scler 19 11 Suppl. 2013 74 558
    • (2013) Mult Scler , vol.19 , Issue.11 , pp. 74-558
    • Bermel, R.1    Hashmonay, R.2    Meng, X.3
  • 94
    • 84880391860 scopus 로고    scopus 로고
    • Initiating oral fingolimod treatment in patients with multiple sclerosis
    • B.A. Singer Initiating oral fingolimod treatment in patients with multiple sclerosis Ther Adv Neurol Disord 6 2013 269 275
    • (2013) Ther Adv Neurol Disord , vol.6 , pp. 269-275
    • Singer, B.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.